News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) to Participate in the Needham Healthcare Conference


4/29/2013 6:30:04 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dyax Corp. (NASDAQ: DYAX) announced today that the Company will participate in the Needham Healthcare Conference, being held April 30-May 1, 2013, at the Westin New York Grand Central Hotel in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Tuesday, April 30 at 10:40 AM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® (ecallantide) and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES